ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Salmon To Step Down As Center Director; Becker To Relinquish Positions At MDACC

September 4, 1998

QOL With Femara Comparable To Placebo, Analysis Finds

December 26, 2003

Search for New NCI director focuses On California; Possibilities Include Korn, Beahrs, Gale, Others

September 23, 1988

RFP Available; Program Announcement

April 16, 1993

Barbara Rimer Named NCAB Chairman; First Women Appointed To Lead Board

September 16, 1994

Bloch Pushes PDQ Promotion To Public, But NCAB Limits It to Physicians

February 17, 1984